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Objective: To determine the effectiveness of ultrasound screening for developmental dysplasia of the hip
(DDH) after the neonatal period.
Design: Prospective cohort study.
Setting: Child health care centres.
Participants: Infants attending the child health care centres.
Interventions: The intervention group (n = 5170) was screened by ultrasound at 1, 2, and 3 months of
age. The control group (n = 2066) was screened by routine physical examination as part of the
programme for child health surveillance at the child health care centres (CHC screening). For evaluation of
the screening, the children in both the intervention and control group received an ultrasound examination
after 6 months of age to detect any abnormality that might have been missed by the screening.
Results: The sensitivity of the ultrasound screening was 88.5%, and the referral rate 7.6%. As a result of the
ultrasound screening, 4.6% of the children were treated. The sensitivity of the CHC screening was 76.4%,
with a referral rate of 19.2%. The treatment rate was 2.7%. Of the treated children in the ultrasound
screening group, 67% were referred before the age of 13 weeks, whereas in the CHC screening group
only 29% were referred before this age.
Conclusions: This study shows that ultrasound screening detects more children with DDH than CHC
screening and that more of them are detected at an earlier age. To accomplish this, even fewer children
have to be referred. However, even general ultrasound screening seems not to eradicate late cases of
DDH. The higher treatment rate in the population screened by ultrasound may be a result of overtreatment.
E
arly diagnosis and treatment of developmental dysplasia
of the hip (DDH) is considered to be very important for
its prognosis and outcome.1 In 1962, both Von Rosen
and Barlow published a screening test, called the Ortolani
test and the Barlow test respectively, for the early detection of
congenital dislocation of the hip in neonates.2 3 Since then,
routine neonatal screening for DDH has been introduced
world wide.4 Despite these neonatal screening programmes,
late cases still arise.5 6
A more sensitive diagnostic test for DDH is ultrasono-
graphy, which was introduced by Graf in 1980.7 General
neonatal ultrasound screening has been advocated and is
nowadays a standard procedure in Germany, Austria, and
Switzerland.8–10 In spite of the positive results reported,
ultrasound screening has not yet been adopted in other
countries because of the large costs of general ultrasound
screening. These comprise the costs of organising and
performing the screening (staff, facilities, and equipment)
and the costs for additional diagnostic procedures. A second
reason for rejecting ultrasound screening is the presumed risk
of overtreatment when applied at a very young age.11–13
Postponing the screening beyond the neonatal period has
been suggested to reduce the risk of overtreatment.
Consensus on the best age for ultrasound screening has,
however, not been reached.11 14 15 Moreover, ultrasound
screening after the neonatal period is difficult to implement
in most countries because it is hard to ensure that all children
are examined.15 In contrast, in the Netherlands, neonatal
screening is difficult to achieve because of the large
percentage of home deliveries.16 Instead, screening for DDH
has become a part of the programme for child health surveil-
lance, which has been organised by the child health care
(CHC) centres. The CHC screening is based on identification
of risk factors and repeated physical examination of the hip
(abduction test and Galeazzi test) in children aged 1–
5 months. As the validity of this screening programme was
not satisfactory, we investigated whether ultrasound screen-
ing after the neonatal period yields better results.17 A large
prospective cohort study, called the Soundchec study, was set
up in the Netherlands in 1998 to investigate the value of
ultrasound screening for DDH and to determine the best age
at which to perform it. The children in the intervention
population were screened by ultrasound examinations of the
hip by Graf’s method from the age of 1 month onwards.18 In
this paper, the results of the screening programme as
performed in the Soundchec study are compared with the
results of standardised CHC screening for DDH as reported by
Boere-Boonekamp et al in 1998.17
MATERIALS AND METHODS
Intervention population
The intervention population comprised all children born in
the catchment areas of two CHC organisations in the Eastern
part of the Netherlands between 1 September 1998 and 30
November 1999 (n = 6259). Informed parental consent was
obtained before participation in the study. The children were
screened by an ultrasound examination of the hip at the age
of 1, 2, and 3 months. For evaluation purposes, the children
received an additional ultrasound examination at 8 months
of age (reference test) to detect any abnormality that may
have been missed by the ultrasound screening examinations
or that developed after the last screening examination.
The ultrasound examinations were performed by radiology
technicians using Graf’s method during a special session at
the CHC centre.18 The technicians were trained in hip
Abbreviations: CHC, child health care; DDH, developmental dysplasia
of the hip
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sonography by Professor Graf or by the project team
(radiologist, orthopaedic resident, orthopaedic surgeon, and
CHC doctor) according to Graf’s principles. The technicians
performed the examinations under supervision of this project
team. A portable sonograph with real time imaging was used
for the ultrasound examinations. The apparatus (Hitachi
EUB-405) was equipped with a linear array transducer
operating on an ultrasound frequency of 7.5 or 5 MHz
(EUP-L33). A location device and a probe guiding device were
used to standardise the infant positioning and scanning
technique.19
At the first screening, only children with decentred hips
(type D or worse) were referred. Severe immature (severe
type IIa2) and abnormal hips (type IIb or worse) were
indications for referral at the second and third screening. At
the reference examination, all infants with abnormal results
(type IIb or worse) were referred. The children who met the
criteria were referred to a radiologist or an orthopaedic
surgeon in the regional hospitals for diagnostic evaluation. In
addition to being screened by ultrasound, the children in the
intervention group were also examined according to the
Dutch standardised assessment protocol by the CHC doctor as
part of the programme for child health surveillance; only
children with a sustained abnormal physical examination
were referred for further diagnostic work up. In the referred
children, the diagnosis DDH was established by the radi-
ologist or orthopaedic surgeon based on the outcome of
additional diagnostic procedures.
The diagnostic evaluation usually consisted of a clinical
and a radiological or sonographic examination of the hip. The
choice between radiological examination using the criteria of
To¨nnis and Brunken20 and ultrasound using Graf’s method18
depended on the expertise of the doctor involved.
Information on these diagnostic procedures, diagnosis,
treatment, and outcome of treatment was obtained by careful
examination of the medical records after parents had given
their permission.
Control population
The control population comprised all children born in the
catchment area of a CHC organisation in the eastern part of
the Netherlands between 1 November 1992 and 31 December
1993 (n = 2105).17 The children were screened for DDH
according to a standardised assessment protocol, which is the
routine screening programme for DDH, and received an
ultrasound reference examination at the age of 6 months for
the purpose of evaluation. The CHC screening is based on
identification of risk factors and repeated physical examina-
tion of the hip. The risk factors considered are a positive
family history of DDH in first or second degree relatives, a
breech presentation or specific abnormalities at physical
examination (torticollis, foot abnormalities, neurological
disorders). The physical examination of the hip consists of
the abduction test and the Galeazzi test. Limited abduction is
a clinical manifestation of a contracture of the adductor
muscles, which is often present in dislocated and dys-
plastic hips. The Galeazzi sign—that is, a difference in knee
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Figure 1 Schematic representation of the results of a post-neonatal ultrasound screening for developmental dysplasia of the hip with every child
scheduled to undergo three ultrasound screening examinations in the first four months. *Four children were not treated until they were referred again at
the ultrasound reference examination. US, Ultrasound; US ref, ultrasound reference examination; neg, negative; pos, positive.
Table 1 Sonographic results according to Graf’s
classification and treatment rate per hip type in 5170
children screened by ultrasound up to three times in the
first 4 months of life
Sonographic hip type
(worst affected hip) Screening results Children treated
I (normal) 3227 (62.4) 13 (0.4)
IIa/IIa+ (immature) 1510 (29.2) 32 (2.1)
IIa2 (immature) 144 (2.8) 42 (29.2)
IIb (abnormal) 100 (1.9) 52 (52.0)
IIc (abnormal) 38 (0.7) 20 (52.6)
D (abnormal) 113 (2.2) 84 (74.3)
III (abnormal) 37 (0.7) 26 (70.3)
IV (abnormal) 1 (0.02) 1 (100.0)
Total 5170 (100) 270 (5.2)
Values are n (%).
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height—is an indication of apparent femoral shortening
due to unilateral hip dislocation.1 Information on risk
factors, physical examination, and referrals was registered
after parental consent was obtained.
Statistical analysis
Differences in prevalence of risk factors between the two
populations were tested using x2 tests. Effectiveness of both
screening programmes was analysed by a two by three table
instead of the classical two by two table.21 In this two by three
table, cases of DDH were divided into those diagnosed as a
direct consequence of an abnormal finding in the screening
programme and those diagnosed otherwise. Children who
screened positive but whose DDH was nevertheless not
detected at that time, but later on, actually did not benefit
from the screening. Sensitivity was therefore defined as the
screen positive children with screen detected DDH divided by
all children with DDH. Other variables on which the
screening programmes were evaluated were the referral rate,
the age at referral, the treatment rate, the percentage of late
detected cases, and the percentage of inpatient treatments.
RESULTS
In the unselected birth cohorts of the intervention and
control population, the parents of 5170 children (82.6%) and
2066 (98.1%) respectively agreed to participate. The inter-
vention group had a slightly higher risk of DDH; significantly
more infants in the intervention group were firstborn
children (47.4% v 41.1 %) and had affected relatives both in
the first or second degree (11.2% v 7.6%) and in the third or
fourth degree (13.6% v 10.2%) compared with the infants in
the control group. There was no significant difference
between the two groups with regard to sex, breech position,
abnormalities of the feet, torticollis, and neurological
disorders.
Ultrasound screening
In total, 5170 children participated in the ultrasound screen-
ing programme and were screened 2.7 times on average.
Figure 1 is a schematic representation of the results. An
abnormal ultrasound examination (type IIb or worse) on one
or more occasions was found in 289 children (table 1). Of
these children, 271 were referred for further diagnostic
evaluation. In addition, 65 children with type IIa2 hips, 20
children with type IIa hips, and three children with normal
but suspect hips were referred for further diagnostic
evaluation. Of these 359 referred children, 231 were subse-
quently treated for DDH. Another four children were initially
judged not to require treatment, but were treated for DDH
after an abnormal finding in the ultrasound reference
Figure 2 Sonograms of two non-
treated children with type D hips at the
age of 5 weeks (A and C) and normal
hips at the age of 35 and 32 weeks
respectively (B and D).
Table 2 Results of the ultrasound and child health care (CHC) screening for
developmental dysplasia of the hip (DDH) in modified two by two tables
DDH+
DDH2 TotalScreen detected Not screen detected
Ultrasound screening + 239 4 149 392
Ultrasound screening 2 0 27 4751 4778
Total 239 31 4900 5170
CHC screening + 55 7 335 397
CHC screening 2 0 10 1659 1669
Total 55 27 1994 2066
Ultrasound screening for hip dysplasia F27
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examination (type IIb) at the age of 8 months. The
sonographic hip types of these four children in the screening
were type IIa2, type IIb, and type D. Pelvic radiographs,
produced at the age of at least 3 months, were assessed as
normal. In three cases there appeared to be a discrepancy
between the radiograph and the ultrasound (borderline
cases). In retrospect, the radiograph of the fourth case had
erroneously been classified as normal.
Thirty three children with an immature or abnormal
ultrasound examination who were not referred at that time
failed to complete the screening programme. Of these, eight
were treated after a referral by the CHC doctor.
Of the children with normal ultrasound screening exam-
inations, 27 were treated for DDH. The hips of these children
were normal on all screening examinations or were immature
(type IIa or type IIa2) at first, but turned out to be normal
(type I) on subsequent screening examinations. The children
were referred because of an abnormal ultrasound reference
examination (n = 7), an abnormal physical examination at
the CHC centre (n = 19), or a positive family history of DDH
(n = 1). Most of these children were treated because the hip
was dysplastic on pelvic radiographs. Because it is uncom-
mon for sonographically normal hips to deteriorate, a panel
of one radiologist and two orthopaedic surgeons reviewed the
radiographs of 19 of these children. They judged 13 as being
normal, five as abnormal, and one as not assessable.
All 4900 children who were not treated for DDH were
scheduled to have an ultrasound examination at the age of
8 months to check for hip abnormalities missed by ultra-
sound screening. This examination resulted in seven addi-
tional cases being detected. The negative status was
confirmed by the ultrasound reference examination in
93.6% of the 4900 children, and diagnostic evaluation in
the hospital was negative in another 0.8%. The reference
examination confirmed that sonographically abnormal hips
of children who were referred but not treated did actually
resolve without treatment. Figure 2 gives an illustration of
two of these cases. Although the parents were reminded of
the reference examination, 273 children (5.6%) were lost to
follow up (fig 1). In total, 270 children were treated for DDH.
Of these children, 231 were detected by the ultrasound
screening and were treated early. Eight children who did not
complete the screening programme were also treated after a
referral by the CHC doctor. We counted them as screen
detected cases because their hips were not normal at the last
screening examination. Twenty seven children treated for
DDH were not detected by the screening. Four children were
treated after a referral at the ultrasound reference examina-
tion, although they had been referred before. They were
considered as missed cases because they were not diagnosed
as a consequence of the screening. Therefore the sensitivity of
the ultrasound screening programme in detecting cases with
DDH early was 88.5% (239/270, 95% confidence interval
84.1% to 92.1%) with a referral rate of 7.6% (tables 2 and 3).
The percentage of children treated early was 4.6%. Inpatient
treatment was seen in less than one child per 1000 screened
children. The median age of the children at hospital
admission was 25 weeks (range 14–27).
CHC screening
In total, 2066 children attended the CHC centre to participate
in the screening for DDH. On average, the children were
examined 3.6 times by the CHC doctor. Of all the children,
19.2% were referred because of a positive family history of
DDH in first or second degree relatives, a breech position
during the last trimester of pregnancy, an abnormal finding
on the physical examination of the hip, or because of other
abnormalities (feet, torticollis, neurological disorders). In 55
of these children, the diagnosis was confirmed immediately.
The hips of seven children were first judged to be normal, but
they were treated for DDH after a referral at the ultrasound
reference examination. In addition, 10 out of the 1669 screen
negative children were treated after an abnormal finding on
the ultrasound reference examination. Of the 1994 children
who were not treated, 91.4% had a negative ultrasound
reference examination, 3.7% had a negative examination in
the hospital, and 4.9% were lost to follow up.
The sensitivity of the CHC screening to detect children with
DDH early was 76.4% (55/72, 95% confidence interval 64.9%
to 85.6%) (tables 2 and 3). The percentage of children treated
early was 2.7%. Three per 1000 screened children were
admitted to hospital for DDH; the median age was 19 weeks
(range 15–43).
Table 3 Results and consequences of the ultrasound and child health care (CHC)
screening for developmental dysplasia of the hip
Ultrasound
screening
(n = 5170) 95% CI
CHC screening
(n = 2066) 95% CI
Sensitivity (%) 88.5 84.1 to 92.1 76.4 64.9 to 85.6
Referred children (%) 7.6 6.9 to 8.3 19.2 17.5 to 21.0
Children treated early (%) 4.6 4.1 to 5.2 2.7 2.0 to 3.5
Late detected cases (%) 0.6 0.4 to 0.9 0.8 0.6 to 1.3
Inpatient treatment per 1000 screened
children
1 0 to 2 3 1 to 7
CI, Confidence interval.
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Figure 3 Age at referral of treated children participating in the
ultrasound and child health care (CHC) screening. DDH, Developmental
dysplasia of the hip. Dotted line: treated children who had not been
detected by screening.
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Comparison of ultrasound and CHC screening
Table 3 summarises the performance of both screening
programmes for DDH and the consequences of the pro-
grammes. As significantly more children in the intervention
group were firstborn children and had affected relatives
compared with the children in the control group, the
treatment rate was expected to be higher in the intervention
group. Indirect standardisation of these risk factors showed
that the expected treatment rate in the intervention group
(including late cases) was 3.8% instead of 3.5%.
When the ages at referral are compared, another difference
between the two screening programmes can be seen (fig 3):
the cases in the ultrasound screening group were referred at
an earlier age than those in the CHC screening group. The
children in the ultrasound screening group can therefore be
treated earlier, which may result in shorter treatment and
better results. That the ultrasound screening resulted in a
higher percentage of children being treated is also evident.
DISCUSSION
The sensitivity of the ultrasound screening programme in the
Soundchec study was 88.5% compared with 76.4% for the
routine CHC screening programme in the Netherlands.
Remarkably, this higher sensitivity went together with a
decrease in referral rate from 19.2% to 7.6%. In addition, 67%
of cases in the ultrasound screening group were referred
before the age of 13 weeks. This is much higher than the 29%
of cases in the CHC group referred before the age of
13 weeks.
It was disappointing that 11.5% of the cases of DDH—that
is, six cases per 1000 screened children—were not detected by
ultrasound screening, but only by active follow up of all
children at the CHC centres or by the ultrasound reference
examination at the age of 8 months. However, review of the
diagnostic radiographs of these missed cases question the
reliability of this finding. If almost 70% of the missed cases
were not true cases of DDH, the sensitivity of the ultrasound
screening would be 95% and the rate of missed cases 2.5 per
1000 children screened. Rosendahl et al22 also reported the
occurrence of late cases. Their rate was lower, with 1.4 late
cases per 1000 screened children. This is an interesting
phenomenon, all the more because their screening pro-
gramme was confined to one ultrasound examination with
repeat screening of only immature hips. Lewis et al23 did not
detect any late cases in their population screened by
ultrasound. A drawback of both studies is, however, the lack
of active follow up of all screened children. Therefore it is
most likely that not all late cases of DDH have been detected,
especially those of dysplastic hips without dislocation.
It has largely been accepted that neonatal ultrasound
screening carries the risk of overtreatment because some of
the neonatal sonographically abnormal hips resolve without
treatment.11 24 25 For that reason, the children in the
Soundchec study were first screened at the age of 1 month.
Nevertheless, the treatment rate in the intervention group
was high compared with that in the control group. In both
the intervention and control group, an ultrasound reference
examination at or after the age of 6 months was performed.
Therefore one would not expect to explain the difference in
treatment rate by the fact that not all cases of DDH were
detected in the control group. The slightly higher risk of the
children in the intervention group because of selective
participation also could not account for the difference in
treatment rate between the two groups. Therefore the
difference in treatment rate is most likely explained by some
degree of overtreatment in the population screened by
ultrasound. This means that some of the abnormal hips that
were treated would have normalised if left untreated.
However, at the time treatment was initiated, these two
groups could not be distinguished. Postponing the screening
to the third or fourth month may decrease the risk of
overtreatment, but it will have a negative effect on the age at
referral, and therefore on the age at the start of treatment.
Accepting the idea of overtreatment puts the sensitivity of
ultrasound screening into perspective because overtreatment
leads to overestimation of the sensitivity. However, correction
for overtreatment resulted in a sensitivity of 84.2%, which is
still high compared with the sensitivity of the CHC screening
programme.
Inpatient treatment (primarily traction) was more often
indicated in the control population than the population
screened by ultrasound. However, it is unclear whether this
difference is a consequence of the ultrasound screening or a
consequence of the treatment protocol, which has been
changed; in 1993 most dislocations were treated by traction,
in 1998 the Pavlik harness was usually the treatment of
choice. As a result, in the intervention group, traction was
started after abduction treatment had failed, whereas in the
control group, traction was applied immediately after the
diagnosis had been made (except for one child).
In conclusion, this study shows that ultrasound screening
detects more children with DDH than CHC screening and
that more of them are detected at an earlier age. To
accomplish this, even fewer children have to be referred.
However, general ultrasound screening seems not to eradi-
cate late cases of DDH. The higher treatment rate in the
population screened by ultrasound points to overtreatment as
a consequence of the screening. Prevention of overtreatment
may be accomplished by performing the screening at the age
of 2 or 3 months or by applying a referral protocol with a wait
and see period for at least the immature hips.
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